Health
South African virus mutation raises questions over vaccine effectiveness – The Times of Israel
Scientists express concern over E484K strain, which Cambridge microbiologist warns ‘could be the start of problems for spike vaccines’ developed by Pfizer, Moderna…
PARIS (AFP) — As the British coronavirus variant occupies countries’ pandemic plans due to its increased transmissibility, other mutations to the Sars-CoV-2 are provoking concern among scientists who are scrambling to work out if they will respond to vaccines.
In particular, one mutation, known as E484K, detected initially in South Africa and on subsequent variants in Brazil and Japan, has raised alarm among researchers.
Ravi Gupta, professor of microbiology at the University of Cambridge, said…
-
Noosa News13 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News12 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News21 hours agoCountdown on for Noosa Eat & Drink Festival 2025
-
Noosa News18 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up